Article

Viral rebound occurrence immediately after drug discontinuation involving neither drug resistance nor latent reservoir

2023-08-08

Abstract excerpt

Some viruses exhibit "rebound" when the administration of antiviral drugs is discontinued. Viral rebound caused by resistance mutations or latent reservoirs has been studied mathematically. In this study, we investigated the viral rebound due to other causes. Since immunity is weaker during antiviral treatment than without the treatment, drug discontinuation may increase the viral load. We analyzed the dynamics of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3d5c99f-4843-52be-bde5-8c94aea83b8a
DOI: 10.21203/rs.3.rs-3221901/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Viral rebound occurrence immediately after drug discontinuation involving neither drug resistance nor latent reservoirDOI 10.21203/rs.3.rs-3221901/v1Read

Models of SIV rebound after treatment interruption that involve multiple reactivation eventsSemantic proximity Read

Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infection.Semantic proximity Read

A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral reboundSemantic proximity Read

Life cycle synchronization is a viral drug resistance mechanism.Semantic proximity Read

Probability of resistance evolution for exponentially growing virus in the host.Semantic proximity Read

Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.Semantic proximity Read

[Two-step interferon rebound therapy for refractory chronic hepatitis C].Semantic proximity Read

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIVSemantic proximity Read

Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis BSemantic proximity Read

Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations.Semantic proximity Read

Anti-hepatitis B virus treatment guided by long-term virus kinetics stepwise tracing.Semantic proximity Read

A perspective on modelling hepatitis C virus infectionSemantic proximity Read